FDA Device Intelligence
Home › Heraeus Medical GmbH › PALACOS®

PALACOS®

Heraeus Medical GmbH · Model fast R+G · UDI-DI 04260102136069

LODMBB Prescription
1
510(k) clearances
13,179
Adverse events (469 deaths)
34
Recalls
82
Facilities

Description

PALACOS® fastR+G is an acrylic bone cement for use in orthopedic surgery. It is formed from powder and liquid by exothermic polymerization. It secures the fixation of the grafted artificial joint improving the transfer of forces at the interface implant - bone. The antibiotic gentamicin sulphate has been added to protect the cured cement and contiguous tissue against contamination by microbes sensitive to gentamicin. PALACOS® fastR+G is available in 51 g packaging size. PALACOS® fast R+G is indicated for use as bone cement in arthroplasty procedures of the hip, knee and other joints to fix plastic and metal prosthetic parts to living bone when reconstruction is necessary. The cement is indicated for use in the second stage of a two stage revision for total joint arthroplasty after the initial infection has been cleared.

Recalls

DateFirmReason
2025-12-09Heraeus Medical GmbH (Dental Division)increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule b
2025-12-09Heraeus Medical GmbH (Dental Division)increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule b
2025-12-09Heraeus Medical GmbH (Dental Division)increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule b
2025-12-09Heraeus Medical GmbH (Dental Division)increase of complaints regarding the breakage of the ampoules within their device systems. An extensive investigation revealed that multiple factors have an impact on the ampoule b
2022-11-07Howmedica Osteonics Corp.Instructions for Use (IFU) included in the packaging is missing a translation in the Turkish language. Although the Turkish translation is missing, all content within the IFUs is
2022-11-07Howmedica Osteonics Corp.Instructions for Use (IFU) included in the packaging is missing a translation in the Turkish language. Although the Turkish translation is missing, all content within the IFUs is
2021-03-22BIOPSYBELL S.R.L.Products labeled as sterile were distributed, but may not have been sterilized.
2021-03-22BIOPSYBELL S.R.L.Products labeled as sterile were distributed, but may not have been sterilized.
2021-03-22BIOPSYBELL S.R.L.Products labeled as sterile were distributed, but may not have been sterilized.
2021-03-22BIOPSYBELL S.R.L.Products labeled as sterile were distributed, but may not have been sterilized.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.